TUCSON- The University of Arizona is on the forefront of developing new drugs to prevent and treat Alzheimer’s disease and other neurodegenerative diseases.
Doctor Roberta Diaz Brinton, the inaugural director of the Center for Innovation in Brain Science at the UA Health Sciences, has been awarded a $1.8 million National Institutes Of Health training program grant.
With the money, Doctor Brinton, will develop a training program to acquire a diverse poll of scientists and train the next generation of Alzheimer’s researchers.
When it comes to finding a cure, Dr. Brinton said that her team finished a promising clinical trial of the first regenerative therapeutic for Alzheimer’s disease.
That therapeutic she hopes will help regenerate the brain to restore function.
She said that the next goal is to advance the trial into several hundred people with Alzheimer’s of both genders and people who carry the risk factor.
“Our strategy is quiet innovative, again it is going back and asking what is the cause of the disease, and what is the adaptation to that disease, and then beginning to develop therapeutics that actually target the earliest cause of the disease and also understanding what stage is this person in,” she said.
Dr. Brinton hopes one day they can bring a precision treatment that not only is tailored to a specific individual, but bring the nervous system back to neurological health.